Beardsworth -- A Full Service CRO

08/10/2010
BIOCLINICA PARTNERS WITH AXIO RESEARCH CORPORATION AND BEARDSWORTH CONSULTING GROUP

NEWTOWN, PENSSYLVANIA (August 10, 2010) -- BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced it has created strategic partnerships with twoprivately held clinical research organizations (CROs), Axio Research Corporation and Beardsworth Consulting Group, Inc. Both alliances strengthen the BioClinica Certified Partner Program and provide customers with additional support in complex therapeutic areas of study and data monitoring and management.

06/23/2010
Alison Martin, MD and Robert W. Malone, MD Join Beardsworth

FLEMINGTON, NEW JERSEY (June 23, 2010) -- Beardsworth Consulting Group, Inc. announces the appointments of Alison Martin, MD as the company’s Scientific Advisor, Oncology and Robert W. Malone, MD as the company’s Medical Director, Vaccines.

05/10/2010
Beardsworth’s Art Gertel to Chair Session on Effective Publication Practices at the 46th DIA Annual Meeting June 13-17 in Washington, DC.

FLEMINGTON, NEW JERSEY (May 10, 2010) -- BEARDSWORTH CONSULTING GROUP, INC. is pleased to announce that their VP, Strategic Regulatory Consulting, Medical Writing, & QA – Art Gertel, will chair a panel session at the 46th DIA Annual Meeting (June 13-17, 2010 in Washington, DC). Art’s session will focus on Effective Publication Practices.

02/04/2010
Beardsworth Recertified as a Women-Owned Business

FLEMINGTON, NEW JERSEY (February 4, 2010) -- Beardsworth, a full-service contract research organization (CRO), headquartered in Flemington, New Jersey, was recently recertified as a Women’s Business Enterprise National Council (WBENC)-Certified Women Business Enterprise (WBE).

11/24/2009
Beardsworth® Selects OmniComm Systems’ TrialMaster™ Solution for the Electronic Data Capture (EDC) of a Phase II Vaccine Study

FORT LAUDERDALE, FLORIDA (November 24, 2009) -- OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm’s TrialMaster EDC solution for conducting a Phase II vaccine study. The 3-year, 10-site study is planning to enroll 340 subjects. "After a careful selection process, we chose OmniComm Systems to be our preferred EDC provider,” said Michael J. O’Brien, Beardsworth President and CEO. “OmniComm’s solid reputation, early adoption of industry standards, and the many features and benefits the platform offers, made it a logical choice.”

10/23/2009
Beardsworth Executive Receives Prestigious Industry Award

FLEMINGTON, NEW JERSEY (October 23, 2009) -- Beardsworth, a full-service contract research organization, headquartered in Flemington, New Jersey, announced Art Gertel, Vice-President, Strategic Regulatory Consulting, Medical Writing, and QA, is the 2009 recipient of the prestigious American Medical Writers Association’s, Harold Swanberg Distinguished Service Award.